You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 52 No. 6, June 1995 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Articles
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (108)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

Godfrey D. Pearlson, MBBS; Dean F. Wong, MD, PhD; Larry E. Tune, MD; Christopher A. Ross, MD, PhD; Gary A. Chase, PhD; Jonathan M. Links, PhD; Robert F. Dannals, PhD; Alan A. Wilson, PhD; Hayden T. Ravert, PhD; Henry N. Wagner, Jr, MD; J. Raymond DePaulo, MD

Arch Gen Psychiatry. 1995;52(6):471-477.


Abstract



Background
A prior positron emission tomographic study from The Johns Hopkins University, Baltimore, Md, using N-methylspiperone labeled with carbon 11 reported elevated basal ganglia D2 dopamine receptor density (Bmax) values in neuroleptic-naive schizophrenic patients compared with controls. We have now extended these studies to include patients with bipolar disorder.

Methods
Patients with bipolar disorder (n=14) either had never received neuroleptic medication or had been neuroleptic-free for more than 6 months, and they met DSM-III criteria for currently symptomatic affective disorder. Patients with bipolar disorder were compared with matched schizophrenic patients and normal controls. All received two positron emission tomographic scans, the second of which was preceded by oral administration of haloperidol lactate, to permit the calculation of D2 dopamine receptor Bmax.

Results
Diagnostic groups differed in Bmax by analysis of variance (P<.0001); post hoc tests showed higher Bmax values for psychotic patients with bipolar disorder and schizophrenic patients compared with normal controls and for schizophrenic patients and psychotic patients with bipolar disorder compared with nonpsychotic patients with bipolar disorder. Among patients with bipolar disorder, Bmax values correlated significantly with the severity of psychotic symptoms (r=.63) on the Present State Examination but not with the severity of nonpsychotic mood symptoms.

Conclusions
We conclude that, like schizoprenic patients, patients with psychotic bipolar disorder have elevations of D2 dopamine receptor Bmax values and that such elevations in affective disorder are more closely associated with the presence of psychosis than with mood abnormality. Elevations in dopamine receptor values thus may occur in psychiatric states that are characterized by psychotic symptoms rather than being specific to schizophrenia.



Author Affiliations



From the Departments of Psychiatry and Behavioral Sciences (Drs Pearlson, Tune, Ross, Chase, and DePaulo), Mental Hygiene (Drs Pearlson and Chase), Psychiatric Neuro-Imaging (Dr Pearlson), Radiology (Drs Wong, Links, Dannals, Wilson, Ravert, and Wagner), and Neuroscience (Dr Ross), The Johns Hopkins University, Baltimore, Md. Dr Tune is currently affiliated with Wesley Woods Geriatric Hospital, Emory University, Atlanta, Ga.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder
Bowton et al.
J. Neurosci. 2010;30:6048-6057.
ABSTRACT | FULL TEXT  

Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Reeves et al.
Neurology 2009;72:528-534.
ABSTRACT | FULL TEXT  

Brain Receptor Imaging
Heiss and Herholz
JNM 2006;47:302-312.
ABSTRACT | FULL TEXT  

Imaging strategies in depression
Grasby
J Psychopharmacol 1999;13:346-351.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.